Surgeons treat carpal tunnel without skin incision

CEO secure CE mark for device that offers faster recovery without stitches.

Swiss medtech companies Swibrace and Spirecut have developed a minimally invasive surgical device to treat carpal tunnel and trigger finger—two of the most common hand conditions—without making a skin incision.

“We have developed an instrument allowing us to operate very common conditions affecting the hand, carpal tunnel and trigger finger without skin incision,” said Frédéric Schuind, CEO of both companies.

The device works through a small puncture rather than a traditional surgical cut. “We do a simple puncture and under the skin, we will cut the ligament, make more room for the nerve, and it will solve the problem,” Schuind explained during the Asia Summit on Global Health in Hong Kong.

The result is quicker healing. “The patients call us magicians, because the next day the pain is gone, and they have no stitches, no dressing, and they can go back to all the activities,” he added.

Swibrace and Spirecut secured the CE mark for European sales in early 2024 and have also entered the U.S. market. “I'm here in Asia to find a distributor and to sell the device,” Schuind said.